Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Controlled Trial to Assess the Immunogenicity of a Proposed Paediatric Dosing Schedule of Human Papillomavirus Vaccine
Brief Summary: Primary objective is to determine if antibody responses to HPV types 16 \& 18 are non-inferior after a 2-dose paediatric regimen as compared to a 3-dose adult regimen of Q-HPV vaccination, with responses measured at Month 7.


Options:
A: Arm Label: 0,2,6 month vaccination schedule; Type: ACTIVE_COMPARATOR; Interventions: Biological: Biological: quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine | Arm Label: 0,3,9 month vaccination schedule; Type: ACTIVE_COMPARATOR; Interventions: Biological: Biological: quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine | Arm Label: 0,6,12 month vaccination schedule; Type: ACTIVE_COMPARATOR; Interventions: Biological: Biological: quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine | Arm Label: 0,12,24 month vaccination schedule; Type: ACTIVE_COMPARATOR; Interventions: Biological: Biological: quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine | Intervention Type: BIOLOGICAL; Name: Biological: quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine; Assigned to Arm(s): 0,12,24 month vaccination schedule, 0,2,6 month vaccination schedule, 0,3,9 month vaccination schedule, 0,6,12 month vaccination schedule
B: Arm Label: 16-26 year olds 3 doses HPV Vaccine; Type: ACTIVE_COMPARATOR; Interventions: Biological: HPV (Human Papillomavirus) Vaccine | Arm Label: 3 dose 9-13 HPV Vaccine; Type: ACTIVE_COMPARATOR; Interventions: Biological: HPV (Human Papillomavirus) Vaccine | Arm Label: 2 dose 9-13 yrs HPV Vaccine; Type: ACTIVE_COMPARATOR; Interventions: Biological: HPV (Human Papillomavirus) Vaccine | Intervention Type: BIOLOGICAL; Name: HPV (Human Papillomavirus) Vaccine; Assigned to Arm(s): 16-26 year olds 3 doses HPV Vaccine, 2 dose 9-13 yrs HPV Vaccine, 3 dose 9-13 HPV Vaccine
C: Arm Label: Low-dose V503; Type: EXPERIMENTAL; Interventions: Biological: Experimental: V503 | Arm Label: Mid-dose V503; Type: EXPERIMENTAL; Interventions: Biological: Experimental: V503 | Arm Label: High-dose V503; Type: EXPERIMENTAL; Interventions: Biological: Experimental: V503 | Arm Label: Gardasil; Type: ACTIVE_COMPARATOR; Interventions: Biological: Comparator: GARDASIL, Biological: Experimental: V503 | Intervention Type: BIOLOGICAL; Name: Comparator: GARDASIL; Assigned to Arm(s): Gardasil | Intervention Type: BIOLOGICAL; Name: Experimental: V503; Assigned to Arm(s): Gardasil, High-dose V503, Low-dose V503, Mid-dose V503
D: Arm Label: Group A; Type: EXPERIMENTAL; Interventions: Biological: GSK Biologicals' HPV vaccine (GSK1674330A) | Arm Label: Group B; Type: EXPERIMENTAL; Interventions: Biological: GSK Biologicals' HPV vaccine (GSK1674330A) | Arm Label: Group C; Type: EXPERIMENTAL; Interventions: Biological: GSK Biologicals' HPV vaccine (GSK1674330A) | Arm Label: Group D; Type: EXPERIMENTAL; Interventions: Biological: GSK Biologicals' HPV vaccine (GSK1674330A) | Arm Label: Group E; Type: EXPERIMENTAL; Interventions: Biological: GSK Biologicals' HPV vaccine (GSK1674330A) | Arm Label: Group F; Type: ACTIVE_COMPARATOR; Interventions: Biological: Cervarix TM | Intervention Type: BIOLOGICAL; Name: GSK Biologicals' HPV vaccine (GSK1674330A); Assigned to Arm(s): Group A, Group B, Group C, Group D, Group E | Intervention Type: BIOLOGICAL; Name: Cervarix TM; Assigned to Arm(s): Group F

Answer: B